Key facts
- EnsoData’s last known valuation is $95.0M (May 2022).
- It has raised $51.5M across 5 recorded rounds; the latest was Early Stage VC ($20.0M) in Jun 2025.
- Notable investors include Y Combinator, gBETA, M25, HealthX Ventures, Wisconsin Economic Development — 21 tracked in total.
- EnsoData has filed 7 Form Ds with the SEC since 2016, most recently Jun 2025 ($20.0M sold to 7 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 21 names
- ·Watchlist + deal alerts for EnsoData
Funding rounds
5 roundsAbout EnsoData
Operator of a healthcare technology company intended to provide artificial intelligence-powered software services to improve the quality of care and patient outcomes. The company's platform facilitates artificial intelligence and machine learning to automate complex and time-consuming data interpretation that reduces the sleep study review times, enabling neurology labs to automatically review and score waveform data, reduce their processing time and increase revenue.
- Sector
- Healthcare
- HQ
- Madison, WI, United States
- Founded
- 2015
- Employees
- 60
- Website
- ensodata.com/
- Ownership
- Privately Held (backing)
EnsoData doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in EnsoData shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on EnsoData in its N-PORT filings yet. We sweep new filings monthly.